From Single Cells to Diagnosis: Proteomics Technologies in the Multi‐Omics Landscape of Rare and Mitochondrial Diseases
Proteomics by mass spectrometry has rapidly matured from a niche method into a standard tool. The recent 10‐year trajectory of single‐cell proteomics has opened a new biological dimension for studying disease. Mitochondrial diseases, with their pronounced cell‐to‐cell heterogeneity, are particularly, well‐suited to the...